<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04730089</url>
  </required_header>
  <id_info>
    <org_study_id>EB-EIT</org_study_id>
    <nct_id>NCT04730089</nct_id>
  </id_info>
  <brief_title>Epidural Block Impairs HPV During One-lung Ventilation: an EIT- Based Prospective Observation Study</brief_title>
  <official_title>Epidural Block Impairs Hypoxic Pulmonary Vasoconstriction During One-lung Ventilation: an Electrical Impedance Tomography- Based Prospective Observation Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Zhongshan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai Zhongshan Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Define the effect of epidural block on HPV by EIT.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Epidural block may affect the physiological mechanism of hypoxic pulmonary vasoconstriction,&#xD;
      which is still poorly understood. Electrical impedance tomography might be helpful in&#xD;
      establishing the hypoxemia etiology at bedside via combining regional ventilation and&#xD;
      perfusion information.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2020</start_date>
  <completion_date type="Anticipated">July 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Months</target_duration>
  <primary_outcome>
    <measure>Assess regional distribution of pulmonary perfusion</measure>
    <time_frame>within 24 hours</time_frame>
    <description>To evaluate the effect of epidural block on pulmonary blood flow distribution.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assess oxygenation status</measure>
    <time_frame>within 24 hours</time_frame>
    <description>To evaluate the effect of epidural block by assessing regional distribution of pulmonary perfusion based on indicator dilution and changes at different points in time during varying states of regional ventilation will be evaluated.</description>
  </primary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Epidural Block</condition>
  <condition>Electrical Impedance Tomography</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Electrical impedance tomography</intervention_name>
    <description>A bolus of 10ml 10% NaCl was injected during a respiratory pause (â‰¥10s) through the central venous catheter.The results of arterial blood gas analysis and the data of EIT were collected before the first prone session (time baseline), the end of prone positioning (time P).</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients requiring thoracic surgery are given combined epidural anesthesia.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18 - 80 years Existing central venous and arterial access Chest circumference 70 -&#xD;
             150 cm&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Contraindication to central venous injection of 5 % sodium chloride (NaCl)&#xD;
&#xD;
        Contraindications of PulmoVista 500:&#xD;
&#xD;
        Patients with pacemakers, defibrillators or other electrically active implants Patients&#xD;
        with damaged skin or impaired skin contact of the electrodes due to wound dressings&#xD;
        Patients where the attachment of the patient belt could pose a risk to the patient, e.g.&#xD;
        patients with spinal lesions or fractures Patients with uncontrolled body movements&#xD;
        Extremely obese patients (BMI&gt;50) Patients during pregnancy Patients with massive lung&#xD;
        edema Use during electricity-based therapies, such as electrosurgery or electrocautery Use&#xD;
        in the presence of strong magnetic fields Use in conjunction with other bioimpedance&#xD;
        measurement devices&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ming Zhong, MD, phD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fudan University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ming Zhong, MD, phD</last_name>
    <phone>021-65642662</phone>
    <email>zhong.ming@zs-hospital.sh.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Zhongshan Hospital of Fudan University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ming Zhong, MD, phD</last_name>
    </contact>
    <contact_backup>
      <last_name>Yuxian Wang, BSc</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 25, 2021</study_first_submitted>
  <study_first_submitted_qc>January 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 29, 2021</study_first_posted>
  <last_update_submitted>January 25, 2021</last_update_submitted>
  <last_update_submitted_qc>January 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai Zhongshan Hospital</investigator_affiliation>
    <investigator_full_name>Ming Zhong</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

